Provided by Tiger Trade Technology Pte. Ltd.

Eloxx Pharmaceuticals (Uplisting)

15.98
+0.91006.04%
Volume:16.87K
Turnover:266.48K
Market Cap:64.50M
PE:-5.61
High:16.90
Open:14.20
Low:13.93
Close:15.07
52wk High:23.40
52wk Low:0.0000
Shares:4.04M
Float Shares:2.39M
Volume Ratio:0.36
T/O Rate:0.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8493
EPS(LYR):-5.3408
ROE:-615.23%
ROA:-97.59%
PB:1.39
PE(LYR):-2.99

Loading ...

Eloxx Pharmaceuticals Price Target Maintained with a $43.00/Share by Guggenheim

Dow Jones
·
Aug 24

Analysts Offer Insights on Healthcare Companies: Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Health (AGL)

TIPRANKS
·
Aug 24

Eloxx Pharmaceuticals Price Target Announced at $38.00/Share by LUCID Capital Markets

Dow Jones
·
Aug 20

Eloxx Pharmaceuticals initiated with a Buy at Lucid Capital

TIPRANKS
·
Aug 20

CAMP4 Therapeutics Q2 Loss Per Share Misses Estimates on Non-Cash Derivative Charge

Reuters
·
Aug 14

Grace Therapeutics Q1 Net Loss Widens on Impairment Charges

Reuters
·
Aug 13

Belite Bio Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 13

Spruce Biosciences Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 12

Eloxx Maintained at Buy as Strong Exaluren Pipeline and Solid Cash Runway Support Unchanged $40 Price Target

TIPRANKS
·
Aug 12

Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 12

Eloxx Rugi Bersih Q2 FY26 Melebar 138% Menjadi USD 4,5 Juta

Reuters
·
Aug 12

Eloxx Pharmaceuticals Initiated at Outperform by Lifesci Capital

Dow Jones
·
Jul 23

Eloxx Pharmaceuticals initiated with an Outperform at LifeSci Capital

TIPRANKS
·
Jul 22

Eloxx Pharmaceuticals Initiated at Buy by Guggenheim

Dow Jones
·
Jul 20

U.S. Research Roundup- Anterix, Fidus Investment, Nextpower

Reuters
·
Jul 20

Eloxx Pharmaceuticals initiated with a Buy at Guggenheim

TIPRANKS
·
Jul 20

Eloxx Pharmaceuticals Inc trading halted, volatility trading pause

TIPRANKS
·
Jul 09

NASDAQ Trade Halt Volatility Trading Pause at 11:17 Am

Reuters
·
Jul 09

Eloxx’s EXACT Study Puts Exaluren in Focus for Rare Kidney Disease Investors

TIPRANKS
·
Jul 02

Eloxx Pharmaceuticals initial beneficial ownership filing names Domicilium Real Estate Fund III LP as 10% owner

Reuters
·
Jun 18